{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T07:27:41Z","timestamp":1781854061027,"version":"3.54.5"},"reference-count":315,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000076","name":"National Science Foundation Directorate for Biological Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jbc.2026.111344","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:29:47Z","timestamp":1772670587000},"page":"111344","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Structural landscape of H3K27me3 recognition by protein domains and their potential for inhibition"],"prefix":"10.1016","volume":"302","author":[{"given":"Ruben","family":"Rosas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa F.","family":"Baracaldo-Lancheros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily C.","family":"Dykhuizen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8356-7971","authenticated-orcid":false,"given":"Catherine A.","family":"Musselman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2026.111344_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2023.168376","article-title":"Distinct histone H3 lysine 27 modifications dictate different outcomes of gene transcription","volume":"436","author":"Konuma","year":"2024","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jbc.2026.111344_bib2","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/s41576-022-00499-0","article-title":"Context-specific polycomb mechanisms in development","volume":"23","author":"Kim","year":"2022","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.jbc.2026.111344_bib3","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.molcel.2014.10.001","article-title":"Redundant mechanisms to form silent chromatin at pericentromeric regions rely on BEND3 and DNA methylation","volume":"56","author":"Saksouk","year":"2014","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jbc.2026.111344_bib4","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.molcel.2019.03.011","article-title":"Molecular mechanisms directing PRC2 recruitment and H3K27 methylation","volume":"74","author":"Laugesen","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jbc.2026.111344_bib5","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41576-022-00468-7","article-title":"Histone post-translational modifications - cause and consequence of genome function","volume":"23","author":"Millan-Zambrano","year":"2022","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.jbc.2026.111344_bib6","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1500737","article-title":"Regulation of gene transcription by polycomb proteins","volume":"1","author":"Aranda","year":"2015","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jbc.2026.111344_bib7","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1101\/gad.256354.114","article-title":"Two distinct modes for propagation of histone PTMs across the cell cycle","volume":"29","author":"Alabert","year":"2015","journal-title":"Genes Dev."},{"key":"10.1016\/j.jbc.2026.111344_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3003119","article-title":"The length of the G1 phase is an essential determinant of H3K27me3 landscapes across diverse cell types","volume":"23","author":"Trouth","year":"2025","journal-title":"PLoS Biol."},{"key":"10.1016\/j.jbc.2026.111344_bib9","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.molcel.2020.01.017","article-title":"Replicational dilution of H3K27me3 in Mammalian cells and the role of poised promoters","volume":"78","author":"Jadhav","year":"2020","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jbc.2026.111344_bib10","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1038\/s41588-021-00964-2","article-title":"A cis-acting mechanism mediates transcriptional memory at Polycomb target genes in mammals","volume":"53","author":"Holoch","year":"2021","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jbc.2026.111344_bib11","article-title":"Nucleosome context regulates chromatin reader preference","author":"Marunde","year":"2025","journal-title":"biorxiv"},{"key":"10.1016\/j.jbc.2026.111344_bib12","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1126\/science.1076997","article-title":"Role of histone H3 lysine 27 methylation in polycomb-group silencing","volume":"298","author":"Cao","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.jbc.2026.111344_bib13","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0092-8674(02)00975-3","article-title":"Drosophila enhancer of Zeste\/ESC complexes have a histone H3 methyltransferase activity that marks chromosomal polycomb sites","volume":"111","author":"Czermin","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2026.111344_bib14","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1101\/gad.1035902","article-title":"Histone methyltransferase activity associated with a human multiprotein complex containing the enhancer of Zeste protein","volume":"16","author":"Kuzmichev","year":"2002","journal-title":"Genes Dev."},{"key":"10.1016\/j.jbc.2026.111344_bib15","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1101\/gad.1110503","article-title":"Molecular basis for the discrimination of repressive methyl-lysine marks in histone H3 by Polycomb and HP1 chromodomains","volume":"17","author":"Fischle","year":"2003","journal-title":"Genes Dev."},{"key":"10.1016\/j.jbc.2026.111344_bib16","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1101\/gad.269603","article-title":"Structural basis for specific binding of Polycomb chromodomain to histone H3 methylated at Lys 27","volume":"17","author":"Min","year":"2003","journal-title":"Genes Dev."},{"key":"10.1016\/j.jbc.2026.111344_bib17","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.exphem.2016.12.006","article-title":"Polycomb complexes PRC1 and their function in hematopoiesis","volume":"48","author":"Vidal","year":"2017","journal-title":"Exp Hematol"},{"key":"10.1016\/j.jbc.2026.111344_bib18","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1074\/jbc.M110.191411","article-title":"Recognition and specificity determinants of the human cbx chromodomains","volume":"286","author":"Kaustov","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.111344_bib19","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.chembiol.2014.11.021","article-title":"Small-molecule modulators of methyl-lysine binding for the CBX7 chromodomain","volume":"22","author":"Ren","year":"2015","journal-title":"Chem. Biol."},{"key":"10.1016\/j.jbc.2026.111344_bib20","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.tig.2007.08.006","article-title":"Polycomb Group proteins: an evolutionary perspective","volume":"23","author":"Whitcomb","year":"2007","journal-title":"Trends Genet."},{"key":"10.1016\/j.jbc.2026.111344_bib21","first-page":"827","article-title":"Structural basis for the binding selectivity of human CDY chromodomains cell","volume":"27","author":"Dong","year":"2020","journal-title":"Chem. Biol."},{"key":"10.1016\/j.jbc.2026.111344_bib22","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.molcel.2017.07.011","article-title":"Chromodomain protein CDYL acts as a Crotonyl-CoA hydratase to regulate histone crotonylation and spermatogenesis","volume":"67","author":"Liu","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jbc.2026.111344_bib23","doi-asserted-by":"crossref","first-page":"42414","DOI":"10.1074\/jbc.M111.271064","article-title":"Corepressor protein CDYL functions as a molecular bridge between polycomb repressor complex 2 and repressive chromatin mark trimethylated histone lysine 27","volume":"286","author":"Zhang","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.111344_bib24","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.devcel.2013.07.008","article-title":"CHD5 is required for neurogenesis and has a dual role in facilitating gene expression and polycomb gene repression","volume":"26","author":"Egan","year":"2013","journal-title":"Dev. Cell"},{"key":"10.1016\/j.jbc.2026.111344_bib25","doi-asserted-by":"crossref","first-page":"7287","DOI":"10.1038\/s41467-024-51789-6","article-title":"A repressive H3K36me2 reader mediates Polycomb silencing","volume":"15","author":"Xu","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2026.111344_bib26","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.cell.2014.11.039","article-title":"Product binding enforces the genomic specificity of a yeast polycomb repressive complex","volume":"160","author":"Dumesic","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2026.111344_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005335","article-title":"The chromodomain of LIKE HETEROCHROMATIN PROTEIN 1 is essential for H3K27me3 binding and function during Arabidopsis development","volume":"4","author":"Exner","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2026.111344_bib28","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1038\/emboj.2013.145","article-title":"Arabidopsis MSI1 connects LHP1 to PRC2 complexes","volume":"32","author":"Derkacheva","year":"2013","journal-title":"EMBO J."},{"key":"10.1016\/j.jbc.2026.111344_bib29","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1126\/science.1069473","article-title":"Structure of HP1 chromodomain bound to a lysine 9-Methylated histone H3 tail","volume":"295","author":"Jacobs","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.jbc.2026.111344_bib30","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/jipb.13067","article-title":"A histone H3K27me3 reader cooperates with a family of PHD finger-containing proteins to regulate flowering time in Arabidopsis","volume":"63","author":"Qian","year":"2021","journal-title":"J. Integr. Plant Biol."},{"key":"10.1016\/j.jbc.2026.111344_bib31","doi-asserted-by":"crossref","first-page":"6212","DOI":"10.1038\/s41467-020-20089-0","article-title":"Coupling of H3K27me3 recognition with transcriptional repression through the BAH-PHD-CPL2 complex in Arabidopsis","volume":"11","author":"Zhang","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2026.111344_bib32","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/s41588-018-0187-8","article-title":"EBS is a bivalent histone reader that regulates floral phase transition in Arabidopsis","volume":"50","author":"Yang","year":"2018","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jbc.2026.111344_bib33","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1038\/s41467-018-04836-y","article-title":"Dual recognition of H3K4me3 and H3K27me3 by a plant histone reader SHL","volume":"9","author":"Qian","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2026.111344_bib34","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s13238-016-0243-z","article-title":"The BAH domain of BAHD1 is a histone H3K27me3 reader","volume":"7","author":"Zhao","year":"2016","journal-title":"Protein Cell"},{"key":"10.1016\/j.jbc.2026.111344_bib35","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1038\/s41588-020-00729-3","article-title":"BAHCC1 binds H3K27me3 via a conserved BAH module to mediate gene silencing and oncogenesis","volume":"52","author":"Fan","year":"2020","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jbc.2026.111344_bib36","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1093\/nar\/gkab210","article-title":"A conserved BAH module within mammalian BAHD1 connects H3K27me3 to polycomb gene silencing","volume":"49","author":"Fan","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2026.111344_bib37","doi-asserted-by":"crossref","first-page":"13826","DOI":"10.1073\/pnas.0901259106","article-title":"Human BAHD1 promotes heterochromatic gene silencing","volume":"106","author":"Bierne","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2026.111344_bib38","doi-asserted-by":"crossref","first-page":"10448","DOI":"10.1093\/nar\/gkab844","article-title":"Fusarium BP1 is a reader of H3K27 methylation","volume":"49","author":"Tang","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2026.111344_bib39","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13059-024-03209-7","article-title":"Liquid-liquid phase separation of H3K27me3 reader BP1 regulates transcriptional repression","volume":"25","author":"Tang","year":"2024","journal-title":"Genome Biol."},{"key":"10.1016\/j.jbc.2026.111344_bib40","doi-asserted-by":"crossref","first-page":"11614","DOI":"10.1073\/pnas.1918776117","article-title":"Evolutionarily ancient BAH-PHD protein mediates polycomb silencing","volume":"117","author":"Wiles","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2026.111344_bib41","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41586-023-06688-z","article-title":"TNRC18 engages H3K9me3 to mediate silencing of endogenous retrotransposons","volume":"623","author":"Zhao","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2026.111344_bib42","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.tibs.2013.08.002","article-title":"Tudor: a versatile family of histone methylation \u2018readers\u2019","volume":"38","author":"Lu","year":"2013","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.jbc.2026.111344_bib43","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1038\/nsmb.2449","article-title":"Polycomb PHF19 binds H3K36me3 and recruits PRC2 and demethylase NO66 to embryonic stem cell genes during differentiation","volume":"19","author":"Brien","year":"2012","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.jbc.2026.111344_bib44","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1038\/ncomms3969","article-title":"Binding of PHF1 Tudor to H3K36me3 enhances nucleosome accessibility","volume":"4","author":"Musselman","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2026.111344_bib45","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.jmb.2013.08.009","article-title":"The Tudor domain of the PHD finger protein 1 is a dual reader of lysine trimethylation at lysine 36 of histone H3 and lysine 27 of histone variant H3t","volume":"426","author":"Kycia","year":"2014","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jbc.2026.111344_bib46","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.58675","article-title":"Structural basis for histone variant H3tK27me3 recognition by PHF1 and PHF19","volume":"9","author":"Dong","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.jbc.2026.111344_bib47","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1128\/MCB.02017-07","article-title":"Ezh2 requires PHF1 to efficiently catalyze H3 lysine 27 trimethylation in vivo","volume":"28","author":"Sarma","year":"2008","journal-title":"Mol. Cell Biol"},{"key":"10.1016\/j.jbc.2026.111344_bib48","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/ncb1787","article-title":"A model for transmission of the H3K27me3 epigenetic mark","volume":"10","author":"Hansen","year":"2008","journal-title":"Nat. Cell Biol"},{"key":"10.1016\/j.jbc.2026.111344_bib49","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.str.2007.08.007","article-title":"Structural basis of EZH2 recognition by EED","volume":"15","author":"Han","year":"2007","journal-title":"Structure"},{"key":"10.1016\/j.jbc.2026.111344_bib50","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nature08398","article-title":"Role of the polycomb protein EED in the propagation of repressive histone marks","volume":"461","author":"Margueron","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2026.111344_bib51","doi-asserted-by":"crossref","first-page":"19266","DOI":"10.1073\/pnas.1008937107","article-title":"Binding of different histone marks differentially regulates the activity and specificity of polycomb repressive complex 2 (PRC2)","volume":"107","author":"Xu","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2026.111344_bib52","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0968-0004(99)01384-5","article-title":"The WD repeat: a common architecture for diverse functions","volume":"24","author":"Smith","year":"1999","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.jbc.2026.111344_bib53","doi-asserted-by":"crossref","DOI":"10.1126\/science.aac4383","article-title":"Structural basis of histone H3K27 trimethylation by an active polycomb repressive complex 2","volume":"350","author":"Jiao","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.jbc.2026.111344_bib54","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41594-018-0023-y","article-title":"Cryo-EM structures of PRC2 simultaneously engaged with two functionally distinct nucleosomes","volume":"25","author":"Poepsel","year":"2018","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.jbc.2026.111344_bib55","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.cell.2010.10.012","article-title":"Nucleosome-interacting proteins regulated by DNA and histone methylation","volume":"143","author":"Bartke","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2026.111344_bib56","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.cell.2010.08.020","article-title":"Quantitative interaction proteomics and genome-wide profiling of epigenetic histone marks and their readers","volume":"142","author":"Vermeulen","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2026.111344_bib57","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.molcel.2010.01.030","article-title":"Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state","volume":"37","author":"Skene","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jbc.2026.111344_bib58","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.nbd.2003.10.011","article-title":"Expression of the methyl-cpg-binding protein MeCP2 in rat brain. An ontogenetic study","volume":"15","author":"Cassel","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jbc.2026.111344_bib59","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.molcel.2007.12.028","article-title":"MeCP2 binding to DNA depends upon hydration at methyl-CpG","volume":"29","author":"Ho","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jbc.2026.111344_bib60","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1038\/s41467-020-16907-0","article-title":"MeCP2 regulates gene expression through recognition of H3K27me3","volume":"11","author":"Lee","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2026.111344_bib61","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a026708","article-title":"The role of nuclear receptor-binding SET domain family histone lysine methyltransferases in cancer","volume":"7","author":"Bennett","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.jbc.2026.111344_bib62","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkae1121","article-title":"The C-terminal PHDVC5HCH tandem domain of NSD2 is a combinatorial reader of unmodified H3K4 and tri-methylated H3K27 that regulates transcription of cell adhesion genes in multiple myeloma","volume":"53","author":"Berardi","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2026.111344_bib63","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cell.2007.09.026","article-title":"H3K27 demethylases, at long last","volume":"131","author":"Swigut","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2026.111344_bib64","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00018-017-2596-8","article-title":"Orchestration of H3K27 methylation: mechanisms and therapeutic implication","volume":"75","author":"Pan","year":"2018","journal-title":"Cell Mol. Life. Sci."},{"key":"10.1016\/j.jbc.2026.111344_bib65","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1101\/gad.172296.111","article-title":"Structural basis for histone H3 Lys 27 demethylation by UTX\/KDM6A","volume":"25","author":"Sengoku","year":"2011","journal-title":"Genes Dev."},{"key":"10.1016\/j.jbc.2026.111344_bib66","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/nature11262","article-title":"A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response","volume":"488","author":"Kruidenier","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2026.111344_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2025.110239","article-title":"The common yet enigmatic activity of histone tail clipping","volume":"301","author":"Duncan","year":"2025","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.111344_bib68","doi-asserted-by":"crossref","first-page":"5280","DOI":"10.1038\/s41467-021-25568-6","article-title":"Binding of regulatory proteins to nucleosomes is modulated by dynamic histone tails","volume":"12","author":"Peng","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2026.111344_bib69","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1042\/BCJ20230342","article-title":"Beyond the tail: the consequence of context in histone post-translational modification and chromatin research","volume":"481","author":"Weinzapfel","year":"2024","journal-title":"Biochem. J."},{"key":"10.1016\/j.jbc.2026.111344_bib70","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.tibs.2020.12.012","article-title":"Histone tail conformations: a fuzzy affair with DNA","volume":"46","author":"Ghoneim","year":"2021","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.jbc.2026.111344_bib71","article-title":"G34R cancer mutation alters the conformational ensemble and dynamics of the histone H3.3 tails","author":"Fuchs","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.jbc.2026.111344_bib72","doi-asserted-by":"crossref","first-page":"4750","DOI":"10.1093\/nar\/gkab246","article-title":"Nucleosome composition regulates the histone H3 tail conformational ensemble and accessibility","volume":"49","author":"Morrison","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2026.111344_bib73","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.31481","article-title":"The conformation of the histone H3 tail inhibits association of the BPTF PHD finger with the nucleosome","volume":"7","author":"Morrison","year":"2018","journal-title":"eLife"},{"key":"10.1016\/j.jbc.2026.111344_bib74","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1093\/nar\/gky1290","article-title":"Engagement of DNA and H3K27me3 by the CBX8 chromodomain drives chromatin association","volume":"47","author":"Connelly","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2026.111344_bib75","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.bbagrm.2014.03.001","article-title":"Interpreting the language of histone and DNA modifications","volume":"1839","author":"Rothbart","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jbc.2026.111344_bib76","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.molcel.2015.02.013","article-title":"Cbx2 targets PRC1 to constitutive heterochromatin in mouse zygotes in a parent-of-origin-dependent manner","volume":"58","author":"Tardat","year":"2015","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jbc.2026.111344_bib77","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1186\/1471-2164-10-549","article-title":"Novel motifs distinguish multiple homologues of Polycomb in vertebrates: expansion and diversification of the epigenetic toolkit","volume":"10","author":"Senthilkumar","year":"2009","journal-title":"BMC Genomics"},{"key":"10.1016\/j.jbc.2026.111344_bib78","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/s41594-024-01457-6","article-title":"Dynamic PRC1\u2013CBX8 stabilizes a porous structure of chromatin condensates","volume":"32","author":"Uckelmann","year":"2025","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.jbc.2026.111344_bib79","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.17667","article-title":"Live-cell single-molecule tracking reveals co-recognition of H3K27me3 and DNA targets polycomb Cbx7-PRC1 to chromatin","volume":"5","author":"Zhen","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.jbc.2026.111344_bib80","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1126\/science.1232245","article-title":"Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma","volume":"340","author":"Lewis","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.jbc.2026.111344_bib81","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s40478-025-02101-0","article-title":"H3F3B p.K27I-mutant diffuse midline glioma is a distinct subtype of H3K27-altered diffuse midline glioma","volume":"13","author":"Cheng","year":"2025","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.jbc.2026.111344_bib82","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature10833","article-title":"Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma","volume":"482","author":"Schwartzentruber","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2026.111344_bib83","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nm.4036","article-title":"Targeting EZH2 in cancer","volume":"22","author":"Kim","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.jbc.2026.111344_bib84","doi-asserted-by":"crossref","DOI":"10.1177\/15330338211045831","article-title":"CBX2 induces glioma cell proliferation and invasion through the Akt\/PI3K pathway","volume":"20","author":"Wang","year":"2021","journal-title":"Technol. Cancer Res. Treat."},{"key":"10.1016\/j.jbc.2026.111344_bib85","article-title":"CBX2 enhances the progression and TMZ chemoresistance of glioma via EZH2-mediated epigenetic silencing of PTEN expression","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jbc.2026.111344_bib86","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1016\/j.molcel.2025.04.026","article-title":"A specific form of cPRC1 containing CBX4 is co-opted to mediate oncogenic gene repression in diffuse midline glioma","volume":"85","author":"Lagan","year":"2025","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jbc.2026.111344_bib87","article-title":"Altered expression of Polycomb group genes in glioblastoma multiforme","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2026.111344_bib88","doi-asserted-by":"crossref","DOI":"10.1038\/srep27753","article-title":"Cbx7 is epigenetically silenced in glioblastoma and inhibits cell migration by targeting YAP\/TAZ-dependent transcription","volume":"6","author":"Nawaz","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2026.111344_bib89","doi-asserted-by":"crossref","first-page":"26637","DOI":"10.18632\/oncotarget.15789","article-title":"CBX7 is a glioma prognostic marker and induces G 1\/S arrest via the silencing of CCNE1","volume":"8","author":"Yu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jbc.2026.111344_bib90","article-title":"CBX7 reprograms metabolic flux to protect against meningioma progression by modulating the USP44\/c-MYC\/LDHA axis","volume":"15","author":"Cheng","year":"2023","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.jbc.2026.111344_bib91","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.omto.2020.09.012","article-title":"Upregulated CBX8 promotes cancer metastasis via the WNK2\/MMP2 pathway","volume":"19","author":"Jia","year":"2020","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.jbc.2026.111344_bib92","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s00439-021-02283-2","article-title":"Missense and truncating variants in CHD5 in a dominant neurodevelopmental disorder with intellectual disability, behavioral disturbances, and epilepsy","volume":"140","author":"Parenti","year":"2021","journal-title":"Hum. Genet."},{"key":"10.1016\/j.jbc.2026.111344_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216265","article-title":"CDYL knockdown reduces glioma development through an antitumor immune response in the tumor microenvironment","volume":"567","author":"Kong","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jbc.2026.111344_bib94","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.bbrc.2018.07.089","article-title":"microRNA-124a suppresses PHF19 over-expression, EZH2 hyper-activation, and aberrant cell proliferation in human glioma","volume":"503","author":"Lu","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jbc.2026.111344_bib95","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/s41419-018-1082-z","article-title":"PHF19 promotes the proliferation, migration, and chemosensitivity of glioblastoma to doxorubicin through modulation of the SIAH1\/\u03b2\u2013catenin axis","volume":"9","author":"Deng","year":"2018","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jbc.2026.111344_bib96","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1042\/BJ20100944","article-title":"Functional characterization of human Polycomb-like 3 isoforms identifies them as components of distinct EZH2 protein complexes","volume":"434","author":"Boulay","year":"2011","journal-title":"Biochem. J."},{"key":"10.1016\/j.jbc.2026.111344_bib97","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/ajmg.c.31754","article-title":"PRC2-complex related dysfunction in overgrowth syndromes: a review of EZH2, EED, and SUZ12 and their syndromic phenotypes American","volume":"181","author":"Cyrus","year":"2019","journal-title":"J. Med. Genet. C Semin. Med. Genet."},{"key":"10.1016\/j.jbc.2026.111344_bib98","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/hmg\/9.9.1377","article-title":"MECP2 mutations account for most cases of typical forms of Rett syndrome","volume":"9","author":"Bienvenu","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jbc.2026.111344_bib99","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/85899","article-title":"A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome","volume":"27","author":"Guy","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jbc.2026.111344_bib100","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0896-6273(02)00768-7","article-title":"Mice with truncated MeCP2 recapitulate many Rett Syndrome features and display hyperacetylation of Histone H3","volume":"35","author":"Shahbazian","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.jbc.2026.111344_bib101","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nature14319","article-title":"Disruption of DNA-methylation-dependent long gene repression in Rett syndrome","volume":"522","author":"Gabel","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2026.111344_bib102","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1038\/s41436-021-01158-1","article-title":"Loss-of-function and missense variants in NSD2 cause decreased methylation activity and are associated with a distinct developmental phenotype","volume":"23","author":"Zanoni","year":"2021","journal-title":"Genet. Med."},{"key":"10.1016\/j.jbc.2026.111344_bib103","doi-asserted-by":"crossref","DOI":"10.1101\/mcs.a004044","article-title":"De novo loss-of-function variants in NSD2 (WHSC1) associate with a subset of Wolf\u2013Hirschhorn syndrome","volume":"5","author":"Barrie","year":"2019","journal-title":"Cold Spring Harb. Mol. Case Stud"},{"key":"10.1016\/j.jbc.2026.111344_bib104","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nature11213","article-title":"Novel mutations target distinct subgroups of medulloblastoma","volume":"488","author":"Robinson","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2026.111344_bib105","doi-asserted-by":"crossref","first-page":"3630","DOI":"10.1038\/ncomms4630","article-title":"The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes","volume":"5","author":"Huether","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2026.111344_bib106","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.canlet.2020.11.031","article-title":"Histone demethylase UTX\/KDM6A enhances tumor immune cell recruitment, promotes differentiation and suppresses medulloblastoma","volume":"499","author":"Yi","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jbc.2026.111344_bib107","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1158\/1541-7786.MCR-13-0268","article-title":"The histone demethylase Jumonji Coordinates cellular senescence including secretion of neural stem cell\u2013attracting cytokines","volume":"13","author":"Perrigue","year":"2015","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.jbc.2026.111344_bib108","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1158\/1541-7786.MCR-14-0292-T","article-title":"WHSC1 promotes oncogenesis through regulation of NIMA-Related Kinase-7 in squamous cell carcinoma of the head and neck","volume":"13","author":"Saloura","year":"2015","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.jbc.2026.111344_bib109","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.surg.2018.11.015","article-title":"JMJD3 expression is an independent prognosticator in patients with esophageal squamous cell carcinoma","volume":"165","author":"Li","year":"2019","journal-title":"Surgery"},{"key":"10.1016\/j.jbc.2026.111344_bib110","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1172\/JCI96915","article-title":"Notch-effector CSL promotes squamous cell carcinoma by repressing histone demethylase KDM6B","volume":"128","author":"Al Labban","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jbc.2026.111344_bib111","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202153855","article-title":"CBX4 contributes to HIV-1 latency by forming phase-separated nuclear bodies and SUMOylating EZH2","volume":"23","author":"Wu","year":"2022","journal-title":"EMBO Rep."},{"key":"10.1016\/j.jbc.2026.111344_bib112","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/jcmm.14771","article-title":"CBX4 promotes the proliferation and metastasis via regulating BMI-1 in lung cancer","volume":"24","author":"Hu","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.jbc.2026.111344_bib113","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.neo.2020.12.005","article-title":"Chromobox 4 facilitates tumorigenesis of lung adenocarcinoma through the Wnt\/\u03b2-catenin pathway","volume":"23","author":"Wang","year":"2021","journal-title":"Neoplasia"},{"key":"10.1016\/j.jbc.2026.111344_bib114","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.arbres.2022.07.001","article-title":"Long noncoding RNA SNHG5 induces the NF-\u03baB pathway by regulating miR-181c-5p\/CBX4 axis to promote the progression of non-small cell lung cancer","volume":"59","author":"Kang","year":"2023","journal-title":"Arch. Bronconeumol."},{"key":"10.1016\/j.jbc.2026.111344_bib115","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41392-023-01623-0","article-title":"CBX4 deletion promotes tumorigenesis under KrasG12D background by inducing genomic instability","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.jbc.2026.111344_bib116","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.4161\/cc.20022","article-title":"Tumor suppressor activity of CBX7 in lung carcinogenesis","volume":"11","author":"Forzati","year":"2012","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jbc.2026.111344_bib117","article-title":"Chromobox homologue 7 acts as a tumor suppressor in both lung adenocarcinoma and lung squamous cell carcinoma via inhibiting ERK\/MAPK signaling pathway","volume":"2022","author":"Huang","year":"2022","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.jbc.2026.111344_bib118","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1172\/JCI58620","article-title":"CBX7 is a tumor suppressor in mice and humans","volume":"122","author":"Forzati","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jbc.2026.111344_bib119","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.lungcan.2011.11.019","article-title":"CHD5, a tumor suppressor that is epigenetically silenced in lung cancer","volume":"76","author":"Zhao","year":"2012","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jbc.2026.111344_bib120","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.7150\/thno.33680","article-title":"CDYL promotes the chemoresistance of small cell lung cancer by regulating H3K27 trimethylation at the CDKN1C promoter","volume":"9","author":"Qiu","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.jbc.2026.111344_bib121","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.gene.2004.09.006","article-title":"A novel human homologue of Drosophila polycomblike gene is up-regulated in multiple cancers","volume":"343","author":"Wang","year":"2004","journal-title":"Gene"},{"key":"10.1016\/j.jbc.2026.111344_bib122","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1593\/neo.11048","article-title":"Histone lysine methyltransferase Wolf-Hirschhorn Syndrome candidate 1 is involved in human carcinogenesis through regulation of the wnt pathway","volume":"13","author":"Toyokawa","year":"2011","journal-title":"Neoplasia"},{"key":"10.1016\/j.jbc.2026.111344_bib123","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1158\/1078-0432.CCR-10-1302","article-title":"The histone methyltransferase and putative oncoprotein MMSET is overexpressed in a large variety of human tumors","volume":"17","author":"Hudlebusch","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jbc.2026.111344_bib124","doi-asserted-by":"crossref","DOI":"10.1038\/srep32952","article-title":"NSD2 contributes to oncogenic RAS-driven transcription in lung cancer cells through long-range epigenetic activation","volume":"6","author":"Garc\u00eda-Carpizo","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2026.111344_bib125","first-page":"201","article-title":"KDM6B elicits cell apoptosis by promoting nuclear translocation of FOXO1 in non-small","volume":"37","author":"Ma","year":"2015","journal-title":"Cell Lung Cancer Cell Physiol Biochem"},{"key":"10.1016\/j.jbc.2026.111344_bib126","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1093\/hmg\/ddac006","article-title":"Associations of genetic variation in E3 SUMO-protein ligase CBX4 with noise-induced hearing loss","volume":"31","author":"Wang","year":"2022","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jbc.2026.111344_bib127","first-page":"1668","article-title":"Overexpression of CBX2 in breast cancer promotes tumor progression through the PI3K\/AKT signaling pathway","volume":"11","author":"Zheng","year":"2019","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.jbc.2026.111344_bib128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biocel.2017.12.006","article-title":"CBX4 exhibits oncogenic activities in breast cancer via Notch1 signaling","volume":"95","author":"Zeng","year":"2018","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.jbc.2026.111344_bib129","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41598-018-36560-4","article-title":"CBX6 is negatively regulated by EZH2 and plays a potential tumor suppressor role in breast cancer","volume":"9","author":"Deng","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2026.111344_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217409","article-title":"Targeting UBE2T suppresses breast cancer stemness through CBX6-mediated transcriptional repression of SOX2 and NANOG","volume":"611","author":"Wang","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jbc.2026.111344_bib131","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1096\/fj.14-253997","article-title":"CBX7 inhibits breast tumorigenicity through DKK-1-mediated suppression of the Wnt\/\u03b2-catenin pathway the","volume":"29","author":"Kim","year":"2015","journal-title":"FASEB J."},{"key":"10.1016\/j.jbc.2026.111344_bib132","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.celrep.2016.06.002","article-title":"Cbx8 acts non-canonically with Wdr5 to promote mammary tumorigenesis","volume":"16","author":"Chung","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.jbc.2026.111344_bib133","doi-asserted-by":"crossref","first-page":"5242","DOI":"10.7150\/thno.43744","article-title":"Discrete functional and mechanistic roles of chromodomain Y-like 2 (CDYL2) transcript variants in breast cancer growth and metastasis","volume":"10","author":"Yang","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.jbc.2026.111344_bib134","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/s12282-022-01333-5","article-title":"BAHD1 serves as a critical regulator of breast cancer cell proliferation and invasion","volume":"29","author":"Yang","year":"2022","journal-title":"Breast Cancer"},{"key":"10.1016\/j.jbc.2026.111344_bib135","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1074\/jbc.M111.338996","article-title":"Polycomb group protein PHF1 regulates p53-dependent cell growth arrest and apoptosis","volume":"288","author":"Yang","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.111344_bib136","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1158\/0008-5472.CAN-13-1896","article-title":"UTX and MLL4 coordinately regulate transcriptional programs for cell proliferation and invasiveness in breast cancer cells","volume":"74","author":"Kim","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2026.111344_bib137","first-page":"4115","article-title":"Histone-modifier gene expression profiles are associated with pathological and clinical outcomes in human breast cancer","volume":"31","author":"Patani","year":"2011","journal-title":"Anticancer Res."},{"key":"10.1016\/j.jbc.2026.111344_bib138","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.881262","article-title":"High CBX8 expression leads to poor prognosis in laryngeal squamous cell carcinoma by inducing EMT by activating the Wnt\/\u03b2-Catenin signaling pathway","volume":"12","author":"Meng","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jbc.2026.111344_bib139","doi-asserted-by":"crossref","first-page":"6770","DOI":"10.1158\/0008-5472.CAN-08-0695","article-title":"Loss of the CBX7 gene expression correlates with a highly malignant phenotype in thyroid cancer","volume":"68","author":"Pallante","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2026.111344_bib140","doi-asserted-by":"crossref","first-page":"7079","DOI":"10.1158\/0008-5472.CAN-09-1542","article-title":"Chromobox protein homologue 7 protein, with decreased expression in human carcinomas, positively regulates E-cadherin expression by interacting with the histone deacetylase 2 protein","volume":"69","author":"Federico","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2026.111344_bib141","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.7150\/thno.20717","article-title":"CBX8 suppresses tumor metastasis via repressing snail in esophageal squamous cell carcinoma","volume":"7","author":"Wang","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.jbc.2026.111344_bib142","doi-asserted-by":"crossref","first-page":"8010","DOI":"10.18632\/oncotarget.14037","article-title":"CBX7 suppresses cell proliferation, migration, and invasion through the inhibition of PTEN\/Akt signaling in pancreatic cancer","volume":"8","author":"Ni","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jbc.2026.111344_bib143","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.4251\/wjgo.v13.i11.1709","article-title":"Genome-wide CRISPR-Cas9 screening identifies that hypoxia-inducible factor-1a-induced CBX8 transcription promotes pancreatic cancer progression via IRS1\/AKT axis","volume":"13","author":"Teng","year":"2021","journal-title":"World J. Gastrointest. Oncol."},{"key":"10.1016\/j.jbc.2026.111344_bib144","first-page":"47","article-title":"Genomic analyses identify molecular subtypes of pancreatic","volume":"531","author":"Bailey","year":"2016","journal-title":"Cancer Nat."},{"key":"10.1016\/j.jbc.2026.111344_bib145","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1093\/carcin\/bgu136","article-title":"Loss of histone demethylase KDM6B enhances aggressiveness of pancreatic cancer through downregulation of C\/EBP\u03b1","volume":"35","author":"Yamamoto","year":"2014","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jbc.2026.111344_bib146","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2023.113513","article-title":"CBX2-mediated suppression of SIAH2 triggers WNK1 accumulations to promote glycolysis in hepatocellular carcinoma","volume":"426","author":"Xu","year":"2023","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.jbc.2026.111344_bib147","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.7150\/jca.31845","article-title":"CBX2 regulates proliferation and apoptosis via the phosphorylation of YAP in hepatocellular carcinoma","volume":"10","author":"Mao","year":"2019","journal-title":"J Cancer"},{"key":"10.1016\/j.jbc.2026.111344_bib148","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1245\/s10434-013-3171-7","article-title":"Chromobox Homolog 4 is correlated with prognosis and tumor cell growth in hepatocellular carcinoma","volume":"20","author":"Wang","year":"2013","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.jbc.2026.111344_bib149","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ccr.2013.12.008","article-title":"Cbx4 governs HIF-1\u03b1 to potentiate angiogenesis of hepatocellular carcinoma by its SUMO E3 ligase activity","volume":"25","author":"Li","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jbc.2026.111344_bib150","doi-asserted-by":"crossref","first-page":"18872","DOI":"10.18632\/oncotarget.14770","article-title":"CBX6 overexpression contributes to tumor progression and is predictive of a poor prognosis in hepatocellular carcinoma","volume":"8","author":"Zheng","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jbc.2026.111344_bib151","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41419-018-1288-0","article-title":"CBX8 exhibits oncogenic properties and serves as a prognostic factor in hepatocellular carcinoma","volume":"10","author":"Tang","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jbc.2026.111344_bib152","doi-asserted-by":"crossref","first-page":"7123","DOI":"10.18632\/aging.102241","article-title":"Chromobox homolog 8 (CBX8) interacts with Y-box binding Protein 1 (YBX1) to promote cellular proliferation in hepatocellular carcinoma cells","volume":"11","author":"Xiao","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.jbc.2026.111344_bib153","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1158\/0008-5472.CAN-17-0700","article-title":"CBX8 exhibits oncogenic activity via AKT\/\u03b2-Catenin activation in hepatocellular carcinoma","volume":"78","author":"Zhang","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2026.111344_bib154","doi-asserted-by":"crossref","first-page":"40940","DOI":"10.18632\/oncotarget.5724","article-title":"Mutual regulation between CHD5 and EZH2 in hepatocellular carcinoma","volume":"6","author":"Xie","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jbc.2026.111344_bib155","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.781087","article-title":"Comprehensive pan-cancer genomic analysis reveals PHF19 as a carcinogenic indicator related to immune infiltration and prognosis of hepatocellular carcinoma","volume":"12","author":"Zhu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jbc.2026.111344_bib156","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s12253-012-9583-z","article-title":"Overexpression of MMSET is correlation with poor prognosis in hepatocellular carcinoma","volume":"19","author":"Zhou","year":"2013","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.jbc.2026.111344_bib157","doi-asserted-by":"crossref","first-page":"6520","DOI":"10.1158\/0008-5472.CAN-15-3029","article-title":"Aberrant JMJD3 expression upregulates slug to promote migration, invasion, and stem cell\u2013like behaviors in hepatocellular carcinoma","volume":"76","author":"Tang","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2026.111344_bib158","doi-asserted-by":"crossref","first-page":"983","DOI":"10.21037\/jgo-20-223","article-title":"Expression and prognostic value of Chromobox family members in gastric cancer","volume":"11","author":"Ma","year":"2020","journal-title":"J. Gastrointest. Oncol."},{"key":"10.1016\/j.jbc.2026.111344_bib159","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3892\/mmr.2020.11776","article-title":"CBX2 depletion inhibits the proliferation, invasion and migration of gastric cancer cells by inactivating the YAP\/\u03b2-catenin pathway","volume":"23","author":"Zeng","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.jbc.2026.111344_bib160","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/1756-9966-29-114","article-title":"Oncogenic role of the chromobox protein CBX7 in gastric cancer","volume":"29","author":"Zhang","year":"2010","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.jbc.2026.111344_bib161","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13045-018-0562-z","article-title":"CBX7 regulates stem cell-like properties of gastric cancer cells via p16 and AKT-NF-\u03baB-miR-21 pathways","volume":"11","author":"Ni","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jbc.2026.111344_bib162","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1423-0127-16-95","article-title":"CHD5 is down-regulated through promoter hypermethylation in gastric cancer","volume":"16","author":"Wang","year":"2009","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.jbc.2026.111344_bib163","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/s41598-018-37340-w","article-title":"Comprehensive profiling of JMJD3 in gastric cancer and its influence on patient survival","volume":"9","author":"Xu","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2026.111344_bib164","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/sj.onc.1210675","article-title":"Expression and sequence analysis of candidates for the 1p36.31 tumor suppressor gene deleted in neuroblastomas","volume":"27","author":"Okawa","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.jbc.2026.111344_bib165","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.cell.2006.11.052","article-title":"CHD5 is a tumor suppressor at Human 1p36","volume":"128","author":"Bagchi","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2026.111344_bib166","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1158\/1538-7445.AM2016-2433","article-title":"Abstract 2433: loss of chd5-mediated gene repression synergizes with MYCN to accelerate neuroblastoma tumorigenesis in Zebrafish","volume":"76","author":"Zimmerman","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2026.111344_bib167","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1158\/0008-5472.CAN-10-3810","article-title":"MMSET is highly expressed and associated with aggressiveness in Neuroblastoma","volume":"71","author":"Hudlebusch","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2026.111344_bib168","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41389-018-0112-0","article-title":"Histone demethylase KDM6B has an anti-tumorigenic function in neuroblastoma by promoting differentiation","volume":"8","author":"Yang","year":"2019","journal-title":"Oncogenesis"},{"key":"10.1016\/j.jbc.2026.111344_bib169","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1186\/s12935-021-02106-4","article-title":"Expression and prognostic significance of CBX2 in colorectal cancer: database mining for CBX family members in malignancies and vitro analyses","volume":"21","author":"Zhou","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.jbc.2026.111344_bib170","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/s41388-025-03331-1","article-title":"CBX2 as a therapeutic target in colorectal cancer: insights into the altered chromatin accessibility via RUNX1-CBX2-MAP4K1 axis","volume":"44","author":"Wang","year":"2025","journal-title":"Oncogene"},{"key":"10.1016\/j.jbc.2026.111344_bib171","doi-asserted-by":"crossref","first-page":"7277","DOI":"10.1158\/0008-5472.CAN-16-2100","article-title":"CBX4 suppresses metastasis via recruitment of HDAC3 to the Runx2 promoter in colorectal carcinoma","volume":"76","author":"Wang","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2026.111344_bib172","first-page":"597","article-title":"Downregulation of chromobox protein homolog 7 expression in multiple human cancer tissues","volume":"45","author":"Guan","year":"2011","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi"},{"key":"10.1016\/j.jbc.2026.111344_bib173","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1016\/j.ejca.2010.05.011","article-title":"The loss of the CBX7 gene expression represents an adverse prognostic marker for survival of colon carcinoma patients","volume":"46","author":"Pallante","year":"2010","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jbc.2026.111344_bib174","doi-asserted-by":"crossref","first-page":"10778","DOI":"10.18632\/oncotarget.2502","article-title":"Paradoxical role of CBX8 in proliferation and metastasis of colorectal cancer","volume":"5","author":"Tang","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.jbc.2026.111344_bib175","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.3390\/cells11111852","article-title":"High expression of a cancer stemness-related gene, chromobox 8 (CBX8), in normal tissue adjacent to the tumor (NAT) Is associated with poor prognosis of colorectal cancer patients","volume":"11","author":"Ng","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.jbc.2026.111344_bib176","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1245\/s10434-015-4879-3","article-title":"The prognostic significance of histone Lysine demethylase JMJD3\/KDM6B in colorectal cancer","volume":"23","author":"Tokunaga","year":"2016","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.jbc.2026.111344_bib177","doi-asserted-by":"crossref","first-page":"5389","DOI":"10.1073\/pnas.0608721104","article-title":"Role of the chromobox protein CBX7 in lymphomagenesis","volume":"104","author":"Scott","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2026.111344_bib178","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1038\/onc.2010.579","article-title":"The H3K27me3 demethylase, KDM6B, is induced by Epstein\u2013Barr virus and over-expressed in Hodgkin's lymphoma","volume":"30","author":"Anderton","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.jbc.2026.111344_bib179","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3324\/haematol.2016.144964","article-title":"Inhibition of demethylase KDM6B sensitizes diffuse large B-cell lymphoma to chemotherapeutic drugs","volume":"102","author":"Rohit","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.jbc.2026.111344_bib180","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113363","article-title":"Super-enhancer-driven expression of BAHCC1 promotes melanoma cell proliferation and genome stability","volume":"42","author":"Berico","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.jbc.2026.111344_bib181","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.canlet.2014.01.030","article-title":"MEAF6\/PHF1 is a recurrent gene fusion in endometrial stromal sarcoma","volume":"347","author":"Micci","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jbc.2026.111344_bib182","doi-asserted-by":"crossref","first-page":"19203","DOI":"10.18632\/oncotarget.24969","article-title":"Identification of an EPC2-PHF1 fusion transcript in low-grade endometrial stromal sarcoma","volume":"9","author":"Brunetti","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.jbc.2026.111344_bib183","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/gcc.22485","article-title":"Fusion of the genes BRD8 and PHF1 in endometrial stromal sarcoma","volume":"56","author":"Micci","year":"2017","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.jbc.2026.111344_bib184","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/gcc.22845","article-title":"A novel MBTD1-PHF1 gene fusion in endometrial stromal sarcoma: a case report and literature review","volume":"59","author":"Han","year":"2020","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.jbc.2026.111344_bib185","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/gcc.22892","article-title":"Detection of MEAF6-PHF1 translocation in an endometrial stromal nodule","volume":"59","author":"Nomura","year":"2020","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.jbc.2026.111344_bib186","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/jso.23234","article-title":"Overexpression of MMSET in endometrial cancer: a clinicopathologic study","volume":"107","author":"Xiao","year":"2013","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.jbc.2026.111344_bib187","doi-asserted-by":"crossref","DOI":"10.1177\/17448069241260349","article-title":"Upregulation of KDM6B in the anterior cingulate cortex contributes to neonatal maternal deprivation-induced chronic visceral pain in mice","volume":"20","author":"Yi","year":"2024","journal-title":"Mol. Pain"},{"key":"10.1016\/j.jbc.2026.111344_bib188","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/s41416-022-02058-0","article-title":"Downregulation of CBX7 induced by EZH2 upregulates FGFR3 expression to reduce sensitivity to cisplatin in bladder cancer","volume":"128","author":"Ren","year":"2023","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jbc.2026.111344_bib189","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/s41419-021-03819-0","article-title":"CBX7 suppresses urinary bladder cancer progression via modulating AKR1B10\u2013ERK signaling","volume":"12","author":"Huang","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jbc.2026.111344_bib190","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1111\/cas.13383","article-title":"Chromobox homolog 8 is a predictor of muscle invasive bladder cancer and promotes cell proliferation by repressing the p53 pathway","volume":"108","author":"Yuan","year":"2017","journal-title":"Cancer Sci."},{"key":"10.1016\/j.jbc.2026.111344_bib191","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/ng.907","article-title":"Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder","volume":"43","author":"Gui","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jbc.2026.111344_bib192","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3892\/ol.2023.14147","article-title":"CBX7 is involved in the progression of cervical cancer through the ITG\u03b23\/TGF\u03b21\/AKT pathway","volume":"27","author":"Tian","year":"2024","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.jbc.2026.111344_bib193","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1073\/pnas.1009933108","article-title":"Human papillomavirus E7 oncoprotein induces KDM6A and KDM6B histone demethylase expression and causes epigenetic reprogramming","volume":"108","author":"McLaughlin-Drubin","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2026.111344_bib194","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1158\/2767-9764.CRC-24-0027","article-title":"Tumor-Intrinsic activity of chromobox 2 remodels the tumor microenvironment in high-grade serous carcinoma","volume":"4","author":"Iwanaga","year":"2024","journal-title":"Cancer Res. Commun."},{"key":"10.1016\/j.jbc.2026.111344_bib195","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1038\/s41388-020-1269-5","article-title":"CBX7 binds the E-box to inhibit TWIST-1 function and inhibit tumorigenicity and metastatic potential","volume":"39","author":"Li","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.jbc.2026.111344_bib196","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/ijc.28692","article-title":"Expression of chromobox homolog 7 (CBX7) is associated with poor prognosis in ovarian clear cell adenocarcinoma via TRAIL-induced apoptotic pathway regulation","volume":"135","author":"Shinjo","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jbc.2026.111344_bib197","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1158\/1541-7786.MCR-22-0139","article-title":"CBX8 together with SET facilitates ovarian carcinoma growth and metastasis by suppressing the transcription of SUSD2","volume":"20","author":"Wu","year":"2022","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.jbc.2026.111344_bib198","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3109\/1354750X.2013.773082","article-title":"Overexpression of multiple myeloma SET domain (MMSET) is associated with advanced tumor aggressiveness and poor prognosis in serous ovarian carcinoma","volume":"18","author":"Yang","year":"2013","journal-title":"Biomarkers"},{"key":"10.1016\/j.jbc.2026.111344_bib199","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqac047","article-title":"Jumonji domain\u2013containing Protein-3 (JMJD3\/Kdm6b) is critical for normal ovarian function and female fertility","volume":"163","author":"Roy","year":"2022","journal-title":"Endocrinology"},{"key":"10.1016\/j.jbc.2026.111344_bib200","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1002\/cbic.202100118","article-title":"A potent, selective CBX2 chromodomain ligand and its cellular activity during prostate cancer neuroendocrine differentiation","volume":"22","author":"Wang","year":"2021","journal-title":"Chembiochem"},{"key":"10.1016\/j.jbc.2026.111344_bib201","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217987","article-title":"Anti-tumor activity of CDYL2b in prostate cancer","volume":"632","author":"Gu","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jbc.2026.111344_bib202","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.51373","article-title":"PHF19 mediated regulation of proliferation and invasiveness in prostate cancer cells","volume":"9","author":"Jain","year":"2020","journal-title":"eLife"},{"key":"10.1016\/j.jbc.2026.111344_bib203","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1128\/MCB.00204-12","article-title":"Histone methyltransferase NSD2\/MMSET mediates constitutive NF-\u03baB signaling for cancer cell proliferation, survival, and tumor growth via a feed-forward loop","volume":"32","author":"Yang","year":"2012","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.jbc.2026.111344_bib204","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1089\/omi.2015.0113","article-title":"The JMJD3 histone demethylase and the EZH2 histone methyltransferase in prostate cancer","volume":"20","author":"Daures","year":"2016","journal-title":"OMICS"},{"key":"10.1016\/j.jbc.2026.111344_bib205","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1038\/s41379-020-0457-8","article-title":"PHF1 fusions cause distinct gene expression and chromatin accessibility profiles in ossifying fibromyxoid tumors and mesenchymal cells","volume":"33","author":"Hofvander","year":"2020","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.jbc.2026.111344_bib206","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/ng.3095","article-title":"PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors","volume":"46","author":"Lee","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jbc.2026.111344_bib207","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1097\/PAS.0000000000001014","article-title":"Clarifying the distinction between malignant peripheral nerve sheath tumor and dedifferentiated liposarcoma: a critical reappraisal of the diagnostic utility of MDM2 and H3K27me3 status","volume":"42","author":"Makise","year":"2018","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.jbc.2026.111344_bib208","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/s41467-020-14870-4","article-title":"Targeting the CK1\u03b1\/CBX4 axis for metastasis in osteosarcoma","volume":"11","author":"Wang","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2026.111344_bib209","doi-asserted-by":"crossref","first-page":"427","DOI":"10.7150\/jca.13749","article-title":"Chromobox homolog 4 is positively correlated to tumor growth, survival and activation of HIF-1\u03b1 signaling in human osteosarcoma under normoxic condition","volume":"7","author":"Yang","year":"2016","journal-title":"J. Cancer"},{"key":"10.1016\/j.jbc.2026.111344_bib210","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41379-018-0140-5","article-title":"H3K27me3 deficiency defines a subset of dedifferentiated chondrosarcomas with characteristic clinicopathological features","volume":"32","author":"Makise","year":"2019","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.jbc.2026.111344_bib211","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102692","article-title":"CBX4 transcriptionally suppresses KLF6 via interaction with HDAC1 to exert oncogenic activities in clear cell renal cell carcinoma","volume":"53","author":"Jiang","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jbc.2026.111344_bib212","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.7150\/ijbs.69325","article-title":"The RNF26\/CBX7 axis modulates the TNF pathway to promote cell proliferation and regulate sensitivity to TKIs in ccRCC","volume":"18","author":"Liu","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.jbc.2026.111344_bib213","doi-asserted-by":"crossref","first-page":"21618","DOI":"10.18632\/oncotarget.7822","article-title":"The epigenetic modifier CHD5 functions as a novel tumor suppressor for renal cell carcinoma and is predominantly inactivated by promoter CpG methylation","volume":"7","author":"Du","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jbc.2026.111344_bib214","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/ng.349","article-title":"Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer","volume":"41","author":"van Haaften","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jbc.2026.111344_bib215","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/nature08672","article-title":"Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes","volume":"463","author":"Dalgliesh","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2026.111344_bib216","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1186\/1471-2407-12-470","article-title":"Expression and significance of histone H3K27 demethylases in renal cell carcinoma","volume":"12","author":"Shen","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jbc.2026.111344_bib217","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3892\/ol.2020.12212","article-title":"Expression of the epigenetic H3K27me3 modifier genes KDM6A and EZH2 in patients with upper tract urothelial carcinoma","volume":"20","author":"Wang","year":"2020","journal-title":"Oncol Lett."},{"key":"10.1016\/j.jbc.2026.111344_bib218","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.101816","article-title":"Downregulation of the endothelial histone demethylase JMJD3 is associated with neointimal hyperplasia of arteriovenous fistulas in kidney failure","volume":"298","author":"Feng","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.111344_bib219","doi-asserted-by":"crossref","first-page":"19795","DOI":"10.18632\/oncotarget.15047","article-title":"Long noncoding RNA HOTAIR promotes metastasis of renal cell carcinoma by up-regulating histone H3K27 demethylase JMJD3","volume":"8","author":"Xia","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jbc.2026.111344_bib220","first-page":"6334","article-title":"KDM6B induces epithelial-mesenchymal transition and enhances clear cell renal cell carcinoma metastasis through the activation of SLUG","volume":"8","author":"Li","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.jbc.2026.111344_bib221","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12943-022-01603-y","article-title":"CBX2 shapes chromatin accessibility promoting AML via p38 MAPK signaling pathway","volume":"21","author":"Del Gaudio","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jbc.2026.111344_bib222","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ccr.2011.09.008","article-title":"CBX8, a Polycomb Group protein, is essential for MLL-AF9-Induced leukemogenesis","volume":"20","author":"Tan","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jbc.2026.111344_bib223","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1158\/2159-8290.CD-13-0419","article-title":"NUP98\u2013PHF23 is a chromatin-modifying oncoprotein that causes a wide array of leukemias sensitive to inhibition of PHD histone reader function","volume":"4","author":"Gough","year":"2014","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jbc.2026.111344_bib224","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1182\/bloodadvances.2023011320","article-title":"Bahcc1 is critical for the aberrant epigenetic program in a mouse model of MLL-ENL\u2013mediated leukemia","volume":"8","author":"Nakamura","year":"2024","journal-title":"Blood Adv."},{"key":"10.1016\/j.jbc.2026.111344_bib225","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1158\/1541-7786.MCR-19-0852","article-title":"Polycomb-like protein 3 induces proliferation and drug resistance in multiple myeloma and is regulated by miRNA-15a","volume":"18","author":"Yu","year":"2020","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.jbc.2026.111344_bib226","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1182\/blood.2019000578","article-title":"PHF19 promotes multiple myeloma tumorigenicity through PRC2 activation and broad H3K27me3 domain formation","volume":"134","author":"Ren","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jbc.2026.111344_bib227","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.23910","article-title":"PHD finger protein 19 expression in multiple myeloma: association with clinical features, induction therapy outcome, disease progression, and survival","volume":"35","author":"Li","year":"2021","journal-title":"J. Clin. Lab Anal."},{"key":"10.1016\/j.jbc.2026.111344_bib228","article-title":"PHF19 inhibition as a therapeutic target in multiple myeloma Current Research in Translational","volume":"69","author":"Schinke","year":"2021","journal-title":"Medicine"},{"key":"10.1016\/j.jbc.2026.111344_bib229","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.1038\/s41467-024-48327-9","article-title":"1q amplification and PHF19 expressing high-risk cells are associated with relapsed\/refractory multiple myeloma","volume":"15","author":"Johnson","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2026.111344_bib230","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1038\/leu.2012.146","article-title":"EED mutants impair polycomb repressive complex 2 in myelodysplastic syndrome and related neoplasms","volume":"26","author":"Ueda","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.jbc.2026.111344_bib231","doi-asserted-by":"crossref","first-page":"10370","DOI":"10.1073\/pnas.1600070113","article-title":"Propagation of trimethylated H3K27 regulated by polycomb protein EED is required for embryogenesis, hematopoietic maintenance, and tumor suppression","volume":"113","author":"Ueda","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2026.111344_bib232","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nature10725","article-title":"The genetic basis of early T-cell precursor acute lymphoblastic leukaemia","volume":"481","author":"Zhang","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2026.111344_bib233","doi-asserted-by":"crossref","first-page":"6277","DOI":"10.1158\/0008-5472.CAN-13-1000","article-title":"NSD2 is recruited through its PHD domain to oncogenic gene loci to drive multiple myeloma","volume":"73","author":"Huang","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2026.111344_bib234","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.molcel.2011.08.042","article-title":"NSD2 links dimethylation of Histone H3 at lysine 36 to oncogenic programming","volume":"44","author":"Kuo","year":"2011","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jbc.2026.111344_bib235","doi-asserted-by":"crossref","first-page":"4843","DOI":"10.1038\/s41467-019-12811-4","article-title":"NSD2 overexpression drives clustered chromatin and transcriptional changes in a subset of insulated domains","volume":"10","author":"Lhoumaud","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2026.111344_bib236","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.celrep.2017.09.078","article-title":"UTX\/KDM6A loss enhances the malignant phenotype of multiple myeloma and sensitizes cells to EZH2 inhibition","volume":"21","author":"Ezponda","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.jbc.2026.111344_bib237","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nature13605","article-title":"Contrasting roles of histone 3 lysine 27 demethylases in acute lymphoblastic leukaemia","volume":"514","author":"Ntziachristos","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2026.111344_bib238","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1182\/blood-2014-05-577270","article-title":"The H3K27me3 demethylase UTX is a gender-specific tumor suppressor in T-cell acute lymphoblastic leukemia","volume":"125","author":"Van der Meulen","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jbc.2026.111344_bib239","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1038\/leu.2012.56","article-title":"Sequencing histone-modifying enzymes identifies UTX mutations in acute lymphoblastic leukemia","volume":"26","author":"Mar","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.jbc.2026.111344_bib240","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/s41588-018-0114-z","article-title":"UTX-mediated enhancer and chromatin remodeling suppresses myeloid leukemogenesis through noncatalytic inverse regulation of ETS and GATA programs","volume":"50","author":"Gozdecka","year":"2018","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jbc.2026.111344_bib241","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1038\/leu.2013.91","article-title":"Global H3K4me3 genome mapping reveals alterations of innate immunity signaling and overexpression of JMJD3 in human myelodysplastic syndrome CD34+ cell","volume":"27","author":"Wei","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.jbc.2026.111344_bib242","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s00432-018-2631-7","article-title":"Therapeutic potential of GSK-J4, a histone demethylase KDM6B\/JMJD3 inhibitor, for acute myeloid leukemia","volume":"144","author":"Li","year":"2018","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.jbc.2026.111344_bib243","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1038\/s41467-018-05548-z","article-title":"JMJD3 facilitates C\/EBP\u03b2-centered transcriptional program to exert oncorepressor activity in AML","volume":"9","author":"Yu","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2026.111344_bib244","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41586-024-07103-x","article-title":"Mechanisms of action and resistance in histone methylation-targeted therapy","volume":"627","author":"Yamagishi","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2026.111344_bib245","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature11606","article-title":"EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations","volume":"492","author":"McCabe","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2026.111344_bib246","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/s41589-019-0421-4","article-title":"Discovery of a first-in-class EZH2 selective degrader","volume":"16","author":"Ma","year":"2020","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jbc.2026.111344_bib247","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1021\/acs.jmedchem.0c02234","article-title":"Design and synthesis of EZH2-Based PROTACs to degrade the PRC2 complex for targeting the noncatalytic activity of EZH2","volume":"64","author":"Liu","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jbc.2026.111344_bib248","doi-asserted-by":"crossref","first-page":"10167","DOI":"10.1021\/acs.jmedchem.1c00460","article-title":"Design, synthesis, and evaluation of VHL-Based EZH2 degraders to enhance therapeutic activity against lymphoma","volume":"64","author":"Tu","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jbc.2026.111344_bib249","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118106","article-title":"Recent update on the development of EZH2 inhibitors and degraders for cancer therapy","volume":"299","author":"Tang","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jbc.2026.111344_bib250","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116340","article-title":"New FDA oncology small molecule drugs approvals in 2020: mechanism of action and clinical applications","volume":"46","author":"Cristina Mendon\u00e7a Nogueira","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jbc.2026.111344_bib251","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s40265-020-01288-x","article-title":"Tazemetostat: first approval","volume":"80","author":"Hoy","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.jbc.2026.111344_bib252","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1233953","article-title":"Non-canonical functions of EZH2 in cancer","volume":"13","author":"Zimmerman","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jbc.2026.111344_bib253","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116154","article-title":"Discovery of a novel, highly potent EZH2 PROTAC degrader for targeting non-canonical oncogenic functions of EZH2","volume":"267","author":"Velez","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jbc.2026.111344_bib254","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/onc.2015.114","article-title":"Development of secondary mutations in wild-type and mutant EZH2 alleles cooperates to confer resistance to EZH2 inhibitors","volume":"35","author":"Gibaja","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.jbc.2026.111344_bib255","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1158\/2159-8290.CD-23-0110","article-title":"Overcoming clinical resistance to EZH2 inhibition using rational epigenetic combination therapy","volume":"14","author":"Kazansky","year":"2024","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jbc.2026.111344_bib256","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1182\/blood-2017-08-804344","article-title":"Mechanisms of resistance to EZH2 inhibitors in diffuse large B-cell lymphomas","volume":"131","author":"Bisserier","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jbc.2026.111344_bib257","doi-asserted-by":"crossref","first-page":"6873","DOI":"10.7150\/thno.49235","article-title":"Pharmacological inhibition of noncanonical EED-EZH2 signaling overcomes chemoresistance in prostate cancer","volume":"11","author":"Li","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.jbc.2026.111344_bib258","doi-asserted-by":"crossref","first-page":"8194","DOI":"10.1021\/acs.jmedchem.0c02261","article-title":"Structure-Guided development of small-molecule PRC2 inhibitors targeting EZH2\u2013EED interaction","volume":"64","author":"Du","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jbc.2026.111344_bib259","doi-asserted-by":"crossref","first-page":"9512","DOI":"10.1021\/jm501230c","article-title":"Astemizole arrests the proliferation of cancer cells by disrupting the EZH2-EED interaction of Polycomb repressive complex 2","volume":"57","author":"Kong","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jbc.2026.111344_bib260","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nchembio.1331","article-title":"Targeted disruption of the EZH2\u2013EED complex inhibits EZH2-dependent cancer","volume":"9","author":"Kim","year":"2013","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jbc.2026.111344_bib261","doi-asserted-by":"crossref","first-page":"7922","DOI":"10.1073\/pnas.1303800110","article-title":"Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2","volume":"110","author":"Knutson","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2026.111344_bib262","first-page":"161","article-title":"Discovery of peptidomimetic ligands of EED as allosteric inhibitors of PRC2 ACS combinatorial","volume":"19","author":"Barnash","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.jbc.2026.111344_bib263","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nchembio.2306","article-title":"The EED protein\u2013protein interaction inhibitor A-395 inactivates the PRC2 complex","volume":"13","author":"He","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jbc.2026.111344_bib264","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nchembio.2304","article-title":"An allosteric PRC2 inhibitor targeting the H3K27me3 binding pocket of EED","volume":"13","author":"Qi","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jbc.2026.111344_bib265","doi-asserted-by":"crossref","first-page":"5317","DOI":"10.1021\/acs.jmedchem.1c02148","article-title":"Discovery of the clinical candidate MAK683: an EED-Directed, allosteric, and selective PRC2 inhibitor for the treatment of advanced malignancies","volume":"65","author":"Huang","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jbc.2026.111344_bib266","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.127904","article-title":"Free energy perturbation in the design of EED ligands as inhibitors of polycomb repressive complex 2 (PRC2) methyltransferase","volume":"39","author":"O' Donovan","year":"2021","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jbc.2026.111344_bib267","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1158\/1538-7445.AM2025-452","article-title":"Abstract 452: ORIC-944, a PRC2 inhibitor with best-in-class properties, restores luminal features and restricts adaptation in prostate cancer models, conferring synergy with AR pathway inhibitors","volume":"85","author":"Daemen","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2026.111344_bib268","doi-asserted-by":"crossref","first-page":"6586","DOI":"10.1158\/1538-7445.AM2024-6586","article-title":"Abstract 6586: ORIC-944, a potent and selective allosteric PRC2 inhibitor with best-in-class properties, demonstrates combination synergy with AR pathway inhibitors in prostate cancer models","volume":"84","author":"Daemen","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2026.111344_bib269","doi-asserted-by":"crossref","first-page":"14540","DOI":"10.1021\/acs.jmedchem.1c01059","article-title":"Discovery of EEDi-5273 as an exceptionally potent and orally efficacious EED inhibitor capable of achieving complete and persistent tumor regression","volume":"64","author":"Rej","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jbc.2026.111344_bib270","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.chembiol.2019.11.004","article-title":"EED-Targeted PROTACs Degrade EED, EZH2, and SUZ12 in the PRC2 complex","volume":"27","author":"Hsu","year":"2020","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.jbc.2026.111344_bib271","doi-asserted-by":"crossref","first-page":"5587","DOI":"10.1158\/0008-5472.CAN-19-0428","article-title":"An allosteric PRC2 inhibitor targeting EED suppresses tumor progression by modulating the immune response","volume":"79","author":"Dong","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2026.111344_bib272","doi-asserted-by":"crossref","first-page":"7252","DOI":"10.1021\/acs.jmedchem.0c00479","article-title":"EEDi-5285: an exceptionally potent, efficacious, and orally active small-molecule inhibitor of embryonic ectoderm development","volume":"63","author":"Rej","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jbc.2026.111344_bib273","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.chembiol.2019.11.006","article-title":"Degradation of polycomb repressive complex 2 with an EED-targeted bivalent chemical degrader","volume":"27","author":"Potjewyd","year":"2020","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.jbc.2026.111344_bib274","first-page":"2134","article-title":"Rapid identification of novel allosteric PRC2 inhibitors","volume":"14","author":"Read","year":"2019","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.jbc.2026.111344_bib275","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1021\/acschembio.2c00804","article-title":"PROTAC linkerology leads to an optimized bivalent chemical degrader of Polycomb repressive complex 2 (PRC2) components","volume":"18","author":"Bashore","year":"2023","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.jbc.2026.111344_bib276","doi-asserted-by":"crossref","first-page":"17146","DOI":"10.1021\/acs.jmedchem.1c01161","article-title":"Diverse, potent, and efficacious inhibitors that target the EED subunit of the polycomb repressive complex 2 methyltransferase","volume":"64","author":"Bagal","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jbc.2026.111344_bib277","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1021\/acs.jmedchem.2c02028","article-title":"Structure-Based design of the indole-substituted triazolopyrimidines as new EED\u2013H3K27me3 inhibitors for the treatment of lymphoma","volume":"66","author":"Dong","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jbc.2026.111344_bib278","doi-asserted-by":"crossref","first-page":"8510","DOI":"10.1021\/acs.jmedchem.1c00430","article-title":"Discovery of an H3K36me3-Derived peptidomimetic ligand with enhanced affinity for plant homeodomain finger protein 1 (PHF1)","volume":"64","author":"Engelberg","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jbc.2026.111344_bib279","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1021\/acschembio.6b00415","article-title":"Chromodomain ligand optimization via target-class directed combinatorial repurposing","volume":"11","author":"Barnash","year":"2016","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.jbc.2026.111344_bib280","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1021\/acschembio.1c00429","article-title":"A peptidomimetic ligand targeting the chromodomain of MPP8 reveals HRP2\u2019s association with the HUSH complex","volume":"16","author":"Waybright","year":"2021","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.jbc.2026.111344_bib281","article-title":"Discovery and molecular basis of a diverse set of polycomb repressive complex 2 inhibitors recognition by EED","volume":"12","author":"Li","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2026.111344_bib282","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1021\/acs.jmedchem.6b01473","article-title":"Structure-guided design of EED binders allosterically inhibiting the epigenetic Polycomb repressive complex 2 (PRC2) methyltransferase","volume":"60","author":"Lingel","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jbc.2026.111344_bib283","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.115122","article-title":"A first-in-human phase 1\/2 dose-escalation study of MAK683 (EED inhibitor) in patients with advanced malignancies","volume":"216","author":"Ribrag","year":"2025","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jbc.2026.111344_bib284","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1182\/blood-2021-147904","article-title":"Phase I\/II Study of MAK683 in patients with advanced malignancies, including diffuse large B-Cell lymphoma","volume":"138","author":"Ribrag","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jbc.2026.111344_bib285","series-title":"Pharmacokinetic and Efficacy of Orally Administered APG-5918 in Patients with Advanced Solid Tumors or Hematologic Malignancies, NCT05415098, clinicaltrials.gov","year":"2022"},{"key":"10.1016\/j.jbc.2026.111344_bib286","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1182\/blood-2024-202655","article-title":"Embryonic Ectoderm Development (EED) inhibitor APG-5918 demonstrates robust antitumor activity in preclinical models of T-Cell lymphomas (TCLs)","volume":"144","author":"Liang","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.jbc.2026.111344_bib287","doi-asserted-by":"crossref","first-page":"5268","DOI":"10.1182\/blood-2023-185127","article-title":"Embryonic ectoderm development (EED) inhibitor APG5918 improves chronic kidney disease- (CKD)-induced hemoglobin insufficiency in preclinical models anemia","volume":"142","author":"Zhai","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.jbc.2026.111344_bib288","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2024.129968","article-title":"Chemically induced degradation of PRC2 complex by EZH2-Targeted PROTACs via a Ubiquitin-Proteasome pathway","volume":"113","author":"Fu","year":"2024","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jbc.2026.111344_bib289","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.116391","article-title":"PHF19 drives the formation of PRC2 clusters to enhance motility in TNBC cells","volume":"44","author":"Pelzer","year":"2025","journal-title":"Cell Rep."},{"key":"10.1016\/j.jbc.2026.111344_bib290","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/jmcb\/mjx013","article-title":"Chromodomain protein CDYL is required for transmission\/restoration of repressive histone marks","volume":"9","author":"Liu","year":"2017","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.jbc.2026.111344_bib291","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114814","article-title":"The chromodomain protein CDYL confers forebrain identity to human cortical organoids by inhibiting neuronatin","volume":"43","author":"Yang","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.jbc.2026.111344_bib292","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1128\/MCB.00866-13","article-title":"Cdyl, a new partner of the inactive X chromosome and potential reader of H3K27me3 and H3K9me2","volume":"33","author":"Escamilla-Del-Arenal","year":"2013","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.jbc.2026.111344_bib293","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00018-022-04659-7","article-title":"Chromodomain on Y-like 2 (CDYL2) implicated in mitosis and genome stability regulation via interaction with CHAMP1 and POGZ","volume":"80","author":"Siouda","year":"2023","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jbc.2026.111344_bib294","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.117122","article-title":"Regulation, functions and therapeutic strategies of H2AK119ub1","volume":"240","author":"Zhang","year":"2025","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jbc.2026.111344_bib295","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.bbagrm.2016.12.006","article-title":"Compositional and functional diversity of canonical PRC1 complexes in mammals","volume":"1860","author":"Connelly","year":"2017","journal-title":"Biochim. Biophys. Acta Gene Regul. Mech."},{"key":"10.1016\/j.jbc.2026.111344_bib296","first-page":"431","article-title":"CBX chromodomain inhibition enhances chemotherapy response in glioblastoma multiforme Yale","volume":"89","author":"Connelly","year":"2016","journal-title":"J. Biol. Med."},{"key":"10.1016\/j.jbc.2026.111344_bib297","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1002\/cmdc.202100262","article-title":"Polycomb paralog chromodomain inhibitors active against both CBX6 and CBX8","volume":"16","author":"Milosevich","year":"2021","journal-title":"ChemMedChem"},{"key":"10.1016\/j.jbc.2026.111344_bib298","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1039\/D4CB00324A","article-title":"Epigenetic reader chromodomain as a potential therapeutic target","volume":"6","author":"Sharma","year":"2025","journal-title":"RSC Chem. Biol."},{"key":"10.1016\/j.jbc.2026.111344_bib299","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1128\/MCB.26.7.2560-2569.2006","article-title":"Mouse polycomb proteins bind differentially to methylated histone H3 and RNA and are enriched in facultative heterochromatin","volume":"26","author":"Bernstein","year":"2006","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.jbc.2026.111344_bib300","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s10822-011-9505-2","article-title":"Druggability of methyl-lysine binding sites","volume":"25","author":"Santiago","year":"2011","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.jbc.2026.111344_bib301","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/nchembio.2007","article-title":"A cellular chemical probe targeting the chromodomains of Polycomb repressive complex 1","volume":"12","author":"Stuckey","year":"2016","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jbc.2026.111344_bib302","doi-asserted-by":"crossref","first-page":"8913","DOI":"10.1021\/acs.jmedchem.6b00801","article-title":"Structure\u2013Activity relationships and kinetic studies of peptidic antagonists of CBX chromodomains","volume":"59","author":"Stuckey","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jbc.2026.111344_bib303","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1021\/acsmedchemlett.5b00378","article-title":"Selective inhibition of CBX6: a methyllysine reader protein in the polycomb family","volume":"7","author":"Milosevich","year":"2016","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.jbc.2026.111344_bib304","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1021\/acschembio.9b00654","article-title":"Optimization of ligands using focused DNA-Encoded libraries to develop a selective, cell-permeable CBX8 chromodomain inhibitor","volume":"15","author":"Wang","year":"2020","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.jbc.2026.111344_bib305","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1177\/2472555217750871","article-title":"Robustness of in vitro selection assays of DNA-Encoded peptidomimetic ligands to CBX7 and CBX8","volume":"23","author":"Denton","year":"2018","journal-title":"SLAS Discov."},{"key":"10.1016\/j.jbc.2026.111344_bib306","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.chembiol.2019.07.013","article-title":"Discovery and characterization of a cellular potent positive allosteric modulator of the polycomb repressive complex 1 chromodomain, CBX7","volume":"26","author":"Lamb","year":"2019","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.jbc.2026.111344_bib307","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.chembiol.2021.10.003","article-title":"Reprogramming CBX8-PRC1 function with a positive allosteric modulator","volume":"29","author":"Suh","year":"2022","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.jbc.2026.111344_bib308","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.slasd.2022.04.003","article-title":"Identification of two non-peptidergic small molecule inhibitors of CBX2 binding to K27 trimethylated oligonucleosomes","volume":"27","author":"Lercher","year":"2022","journal-title":"SLAS Discov."},{"key":"10.1016\/j.jbc.2026.111344_bib309","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2025.151882","article-title":"Identification of substituted acetanilide compounds as small molecule CBX2 inhibitors via in silico screening","volume":"767","author":"Takase","year":"2025","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jbc.2026.111344_bib310","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1021\/jm401487x","article-title":"Chromodomain antagonists that target the polycomb-group methyllysine reader Protein Chromobox Homolog 7 (CBX7","volume":"57","author":"Simhadri","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jbc.2026.111344_bib311","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1021\/acsmedchemlett.6b00042","article-title":"Structure-Guided discovery of selective antagonists for the chromodomain of polycomb repressive protein CBX7","volume":"7","author":"Ren","year":"2016","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.jbc.2026.111344_bib312","article-title":"Covalent protein inhibitors via tyrosine conjugation with cyclic imine","author":"Wang","year":"2022","journal-title":"Mannich Electrophiles ChemRxiv"},{"key":"10.1016\/j.jbc.2026.111344_bib313","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1038\/nature13688","article-title":"Inhibition of demethylases by GSK-J1\/J4","volume":"514","author":"Heinemann","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2026.111344_bib314","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13148-022-01305-8","article-title":"Therapeutic potential of inhibiting histone 3 lysine 27 demethylases: a review of the literature","volume":"14","author":"Abu-Hanna","year":"2022","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.jbc.2026.111344_bib315","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115232","article-title":"Recent advances in nuclear receptor-binding SET domain 2 (NSD2) inhibitors: an update and perspectives","volume":"250","author":"Zhang","year":"2023","journal-title":"Eur. J. Med. Chem."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925826002140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925826002140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:06:21Z","timestamp":1777457181000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925826002140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":315,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0021925826002140"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2026.111344","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural landscape of H3K27me3 recognition by protein domains and their potential for inhibition","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2026.111344","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"111344"}}